A detailed history of Wealthcare Advisory Partners LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Wealthcare Advisory Partners LLC holds 1,700 shares of MRNA stock, worth $111,775. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,700
Holding current value
$111,775
% of portfolio
0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$101.21 - $166.61 $172,057 - $283,237
1,700 New
1,700 $201,000
Q3 2023

Oct 12, 2023

SELL
$96.41 - $126.61 $54,760 - $71,914
-568 Reduced 17.69%
2,642 $272,000
Q2 2023

Jul 17, 2023

SELL
$118.5 - $160.53 $122,884 - $166,469
-1,037 Reduced 24.42%
3,210 $390,000
Q1 2023

May 04, 2023

SELL
$135.66 - $197.02 $243,102 - $353,059
-1,792 Reduced 29.67%
4,247 $652,000
Q4 2022

Feb 13, 2023

SELL
$118.38 - $210.04 $23,439 - $41,587
-198 Reduced 3.17%
6,039 $1.08 Million
Q3 2022

Nov 14, 2022

SELL
$118.07 - $194.18 $59,389 - $97,672
-503 Reduced 7.46%
6,237 $738,000
Q2 2022

Aug 15, 2022

SELL
$117.13 - $176.59 $12,767 - $19,248
-109 Reduced 1.59%
6,740 $963,000
Q1 2022

Apr 15, 2022

SELL
$126.46 - $235.05 $168,950 - $314,026
-1,336 Reduced 16.32%
6,849 $1.18 Million
Q4 2021

Feb 11, 2022

SELL
$225.82 - $368.51 $144,524 - $235,846
-640 Reduced 7.25%
8,185 $2.08 Million
Q3 2021

Nov 15, 2021

BUY
$221.9 - $484.47 $25,074 - $54,745
113 Added 1.3%
8,825 $3.4 Million
Q2 2021

Aug 16, 2021

BUY
$129.91 - $234.98 $256,832 - $464,555
1,977 Added 29.35%
8,712 $2.05 Million
Q1 2021

Apr 30, 2021

BUY
$109.18 - $185.98 $444,362 - $756,938
4,070 Added 152.72%
6,735 $882,000
Q4 2020

Feb 12, 2021

BUY
$65.74 - $169.86 $175,197 - $452,676
2,665 New
2,665 $278,000
Q2 2020

Jul 29, 2020

SELL
$29.67 - $80.0 $5,192 - $14,000
-175 Closed
0 $0
Q1 2020

Apr 29, 2020

BUY
$17.78 - $31.58 $3,111 - $5,526
175 New
175 $5,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Wealthcare Advisory Partners LLC Portfolio

Follow Wealthcare Advisory Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.